Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism.

  title={Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism.},
  author={Daniel A Rossignol},
  journal={Medical hypotheses},
  volume={68 6},
  • D. Rossignol
  • Published 2007
  • Biology, Medicine
  • Medical hypotheses

Figures and Tables from this paper

Hyperbaric oxygen treatment in autism spectrum disorders
Most studies of HBOT in children with ASD examined changes in behaviors and reported improvements in several behavioral domains although many of these studies were not controlled, and HBOT had minimal adverse effects and was well tolerated.
The effects of hyperbaric oxygen therapy on oxidative stress, inflammation, and symptoms in children with autism: an open-label pilot study
Parental observations support anecdotal accounts of improvement in several domains of autism, and definitive statements regarding the efficacy of HBOT for the treatment of individuals with autism must await results from double-blind, controlled trials.
Therapeutic use of hyperbaric oxygen therapy for children with autism spectrum disorder.
This article reviews important publications regarding the physiologic and clinical influence of HBO on ASD and proposes that low pressure/ low oxygen concentration hyperbaric treatment can improve the clinical manifestations of autism.
Effect of mild hyperbaric oxygen therapy on children diagnosed with autism.
The results do not support the utility of HBO2 in children diagnosed with autism as the primary treatment modality for inflammatory pathways related to neurological disorders.
Drug therapy in autism: a present and future perspective.
Review of the Pathophysiology of Autism and Possible Benefits of Hyperbaric Oxygen Therapy (HBOT)
HBOT in children is generally regarded as safe and many of the underlying pathophysiological findings in autism might be ameliorable with HBOT and these have been reviewed in another publication.
Oxidative stress in Egyptian children with autism: relation to autoimmunity
Evidence of Mitochondrial Dysfunction in Autism and Implications for Treatment
Classical mitochondrial diseases occur in a subset of individuals with autism and are usually caused by genetic anomalies or mitochondrial respiratory pathway deficits. However, in many cases of
Hyperbaric Oxygen Therapy for Children and Youth with Autism Spectrum Disorder: A Review
A review of the literature on whether HBOT as a therapy significantly affects the symptoms of ASD does not confirm its effectiveness and none of the 10 literature reviews indicated that HBOT was a clearly effective form of therapy in the case of ASD.


Hyperbaric oxygen therapy may improve symptoms in autistic children.
Immunity, neuroglia and neuroinflammation in autism
The presence of neuroglial and innate neuroimmune system activation in brain tissue and cerebrospinal fluid of patients with autism is demonstrated, findings that support the view that neuroimmune abnormalities occur in the brain of autistic patients and may contribute to the diversity of the autistic phenotypes.
Neuroglial activation and neuroinflammation in the brain of patients with autism
It is indicated that innate neuroimmune reactions play a pathogenic role in an undefined proportion of autistic patients, suggesting that future therapies might involve modifying neuroglial responses in the brain.
Altered vascular phenotype in autism: correlation with oxidative stress.
Besides enhanced oxidative stress, platelet and vascular endothelium activation also could contribute to the development and clinical manifestations of autism.
Mitochondrial dysfunction in autism spectrum disorders: a population-based study.
Five of 11 patients studied were classified with definite mitochondrial respiratory chain disorder, suggesting that this might be one of the most common disorders associated with autism and warranting further investigation.
Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism
  • S. J. JamesS. Melnyk D. Gaylor
  • Biology
    American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics
  • 2006
It is proposed that an increased vulnerability to oxidative stress (endogenous or environmental) may contribute to the development and clinical manifestations of autism.
Heat shock protein 90 antibodies in autism
Whether a subset of autistic individuals had elevated levels of autoantibodies to hsp90 compared to other study populations was aimed at, based on serendipitous observation of a 90 kDa molecular weight protein in Western blots of the serum of autistic Individuals with compulsive symptomatology that were being analyzed for a different study.
Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism.
The results provided the first statistical research data to show the effectiveness of HBOT in improving blood flow in CND and indicate that HBOT can be an effective part of the treatment for such clients.
Investigation of antioxidant enzymes in children with autistic disorder.
The results indicate that autistic children have low levels of activity of blood antioxidant enzyme systems; if similar abnormalities are present in brain, free radical accumulation could damage brain tissue.